Optimizing the Management of IBS-C and Chronic Constipation: From Timely Diagnosis to Effective Treatment

CAN-eng

$0

gratuit

Mainpro+

15 min

Gastroenterology

0.25 Credits

APPRENDRE ENCORE PLUS

Description du cours

Irritable bowel syndrome (IBS) and chronic constipation (CC) are common gastrointestinal disorders that can significantly impact quality of life, work productivity, and social functioning. This program aims to support clinicians in identifying and managing IBS-C and CC by reviewing Rome V diagnostic criteria, Canadian guideline-based treatment strategies, and practical counselling approaches.

Course Features: 

– 1 video lecture,
– 2 interactive quizzes. 

Content Covered: 

Module: From Diagnosis to Treatment: A Practical and Timely Approach to IBS-C and Chronic Constipation

Microlearning: Reducing Delays in Treating IBS-C and Functional Constipation

This program has received financial support from AbbVie Inc., in the form of an unrestricted educational grant.  

Détails du cours

Date d'expiration : 2027-07-23

Métiers: Médecin

Faculté

  • Jessica Chan, MD, CCFP
  • Naomi Pliamm, MD, CCFP 
  • Yvonne Tse, MD, FRCPC

Accréditation

This activity meets the certification criteria of the College of Family Physicians of Canada and the Quebec College of Family Physicians, a continuing professional development accrediting organization recognized by the Collège des médecins du Québec and has been approved for up to 0.25 Mainpro+® Certified Activity credit(s). 
CERT+ Session ID: 303989-001

Objectif(s) d'apprentissage

Une fois ce programme de formation continue terminé, les participants seront plus en mesure de :

  • Identifier patients with IBS-C or chronic constipation who remain symptomatic despite current management.
  • Apply evidence-based treatment strategies for IBS-C and chronic constipation, including timely escalation to prescription therapies, to improve patient outcomes.
  • Support HCPs in identifying patients with IBS-C and functional constipation who are inadequately managed on OTC therapies and require treatment escalation.